Diabetes mellitus (D.M) is a disease with a high and increasing prevalence. Insulin-producing cells (IPCs) generated from mesenchymal stem cells (MSCs) have shown immense potential for therapy. This study aimed to compare the differentiation potential of 2 kinds of MSCs obtained from human bone marrow (BM), and umbilical cord blood (UCB) into IPCs. In addition, their therapeutic efficiency to control streptozotocin (STZ) -induced diabetic rats was investigated. MSCs were isolated from human BM and UCB, expanded and differentiated to IPCs. The Cells were evaluated by flow cytometry analysis for MSCs markers, RT-PCR for insulin gene expression and ELISA detection of C-peptide release. IPCS were transplanted into the liver of diabetic rats and then evaluated by weekly measurement of the fasting blood glucose (FBG) levels, and detection of in vivo release of C-peptide. This study demonstrated that FBG levels were reduced in diabetic rats transplanted with IPCs, but in rats transplanted with UCB-derived cells were significantly lower than in those transplanted with BM-derived cells. The amount of Cpeptide released from transplanted IPCs derived from BM-MSCs and UCB-MSCs was non-significantly different. The results indicate that UCB-MSCs and BM-MSCs are promising stem cell sources for IPCs that help in the development of a new strategy for treatment of D.M.
Numerous studies have revealed that embryonic stem cells (ESCs), induced pluripotent stem cells (iPSC), and MSCs are able to differentiate into IPCs (Chandra et al., 2011). ESCs posses the highest differentiation potential to IPCs . However, they have the prospect to create benign cystic teratoma and possible destruction of embryos along the way of collection (El-Badri and Ghoneim., 2013).The application of iPS faces many challenges since the high tumorigenic potential of direct reprogramming caused by genome integration and activation of oncogene c-Myc. MSCs have already been employed in several therapeutic applications as therapy for TIDM because of their immunomodulatory properties, low immunogenicity as a result of lack of major histocompatibility complex II(MHC II), and minimal oncogenic risk (Lilly et al., 2016 MNCs were washed twice in 1x PBS and re-suspended in 20 ml of the proliferation medium consisting of low glucose-Dulbecco's Modified Eagle Media (DMEM) (Lonza), 1% penicillin-streptomycin (Lonza), 10 % fetal bovine serum (FBS) (Sigma), and 1% L-glutamine (Lonza). The MNCs were seeded in T75 flasks at a concentration of 5 × 10 6 cells/ml. After 2-3 days of incubation in a 5% CO 2 incubator at 37°C, the non-adherent cells were discarded and the adherents MSCs were cultured. After 5-7 days of cultivation, the confluence of cells reached 80%, so the cells were sub-cultured using trypsinization.
Characterization of Isolated MSCs by Flow Cytometry:
The cells were incubated with mouse monoclonal antibody against human CD90, CD105, and CD45 (R&D systems, USA) for 30 minutes at room temperature. Then, washed and Re-suspended in 200 µL of PBS. Finally, the cells were stained by incubation with a Phycoerythrin (PE)-conjugated Goat Anti-Mouse secondary antibody (Invitrogen Corporation, Grand Island, NY, USA) for 30 minutes. The stained cells were analyzed using a standard BD Accuri ™ C6cytometer and the BD Accuri C6 software (Hu et al., 2013).
Induction of differentiation of BM-MSCs and UCB-MSCs to
IPCs: At passage 3, MSCs were cultured in serum-free, high glucose-DMEM (25mmol/L) with 0.5 mmol/L β-mercaptoethanol (Sigma) for 2 days. Then , the culture medium was changed to serum-free, high glucose medium containing 20 ng/ml basic fibroblast growth factor (Sigma), 1% non-essential amino acids (Sigma), 2% B27 supplement (Gibco BRL, Life Technologies, UK), 20 ng/ml epidermal growth factor (Sigma), and 2 mmol/L L-glutamine (Sigma) for a further 8 days. Finally, the medium was replaced with serum free, high-glucose DMEM containing 10 ng/ml activin-A (Sigma), 10 ng/ml betacellulin (Sigma), 10 mmol/L nicotinamide (Sigma), and 2% B27 supplement for 8 days (Gabr et al., 2013). Reverse Transcription-PCR (RT-PCR) for insulin m.RNA expression: Total RNA was extracted from undifferentiated and differentiated cells using TRIzol reagent (Invitrogen Corporation, Grand Island, NY, USA) in accordance with the producer`s specifications. The purity of RNA was checked at 260 nm using NanoDrop 2000 UV-Vis Spectrophotometer (Thermo SCIENTIFIC, USA).First-strand cDNA was generated by using Sensi-FAST™ c. DNA Synthesis Kit (Bioline, UK).Insulin and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were amplified using an Applied The cycle profile was as follows: initial denaturation at 95°C for 10 minutes, followed by 35 cycles of denaturation at 95 o C for 15 s, primer annealing at 60 o C for 30 s, and extension at 72 o C for 20 s) and the final extension at 72°C for 10 minutes. The PCR products were electrophoresed on 3 % agarose gel stained with ethidium bromide and DNA was visualized via light UV Transilluminator (Model TUV-20, OWL. Scientific, Inc.800 242-5560). Glucose challenge test: The IPCs were incubated in DMEM-low glucose (5.5mM glucose), and the culture medium was collected. Then, the cells were incubated in DMEM-glucose rich (25mM glucose), and then the culture medium was collected. The human Cpeptide concentration was detected in the collected media using Cpeptide ELISA kit (immunospec corporation, Canoga Park, USA) in accordance with the manufacturer`s specifications (Tsai et al., 2012). Transplantation: On the 4th day after STZ injection, the diabetic rats of group II, IV were anesthetized by light ether. The abdominal wall was opened and the liver of diabetic rats was exposed and injected with differentiated UCB-MSCs, BM-MSCs using fine needle syringes in a dose of 2×10 Statistical analysis: Data were analyzed using the SPSS (Statistics Package for Social Sciences) software program version 17.0. Student's t-test is used for comparison between groups (P value of ≤ 0.05 was considered significant).
Results

Morphology and characterization of the cultured MSCs:
The undifferentiated BM-MSCs and UCB-MSCs became adherent spindle shaped. The colony formation could be observed approximately at day 10. At the end of differentiation phase, the cells formed spherical clusters, as shown in figure (1) . Flow-cytometric analysis showed that they expressed high levels of CD90, and CD105, but negligible levels of CD45, as shown in figure (2) . These results revealed that the majority of the cells were MSCs. There is no apparent difference between BM-MSCs and UCB-MSCs in the rate of growth or differentiation. In vitro human C-peptide release in response to a glucose challenge: The IPCs derived from BM-MSCs and UCB-MSCs released a significant increase amount of C-peptide at high glucose medium (25 mM) compared to low glucose medium (5.5mM). There is no significant difference in amount of C-peptide released from BM and UCB-derived cells, as shown in table (1).
Tale (1): C-peptide concentration (ng/ml) in low and high glucose culture media.
IPCs derived from BM Mean ± SD
IPCs derived from UCB Mean ± SD Low glucose medium 0.35 ± 0.10 0.37 ± 0.12 High glucose medium 0.84 ± 0.21 0.84 ± 0.18 P1 <0.001*** <0.001*** (SD: standard deviation, P1: significance between low glucose medium& and high glucose medium).
Outcomes of transplantation:
FBG levels in group III, IV is significantly decreased than group II, however in group IV is significantly decreased than group III, as shown in figure (4).There is no significant difference of C-peptide levels in rats` sera released from transplanted IPCs derived from BM and UCB , as shown in table (2). Fibroblast and epidermal growth factors were used to stimulate proinsulin biosynthesis (Chatterjee et al., 1986) and to play role in clustering of IPCs (Wong ., 2011). Activin A is a member of the transforming growth factor-beta (TGF-β). It was added as it is important for islet development by increasing its insulin content. Betacellulin is a member of epidermal growth factor family. It was used as it helps in regulating the growth of pancreatic endocrine precursor Mohammad El-Nablaway et all ‫ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ‬ ‫ـــــــــــــــــ‬ ‫ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ‬ ‫ــــــــــــــــــــــــــــــــــــــــــــ‬ 138 cells (Demeterco et al., 2000) . Nicotinamide is an effective inducer to maintain islet viability (Kolb and Burkart., 1999). The B-27 supplement was utilized as it contains several components including retinoic acid, insulin and triiodothyronine which support islet cell function and survival (Phelps et al., 2017). This study revealed that BM and UCB-derived cells were negative for CD45, which indicates that they were not hematopoietic stem cells and positive for CD90 and CD105 which indicate that they were MSCs; these findings coincide with Dominici et al., (2006) . Insulin gene expression has been shown with RT-PCR in the differentiated cells. The IPCs were able to secrete c-peptide in larger amounts in response to high glucose concentration in the medium. Transplantation of 2 x10
6 IPCs was sufficient to control hyperglycemia in diabetic rats; this finding coincides with Tsai et al., (2012). Fu et al. (2006) showed that no rejections occur after xenotransplantation of differentiated UCB-MSCs without immunosuppression therapy. In the present study, the liver was used as a site for transplantation of IPCs following the protocol conducted by Chao et al. (2008) . The liver is the most reasonable choice as it is more accessible than the pancreas, and β-cells can produce insulin well in that environment. Hepatocytes and β-cells possess glucosesensing systems, helping them to respond to changes in blood glucose levels (Yang ., 2006). The significant decrease in FBG levels in diabetic rats after transplantation with UCB and BM -derived IPCs coincide with Chao et al., (2008) and Tsai et al., (2014), However, at the end of the present experiment, the FBG levels were higher than control values, these finding coincide with Tsai et al., (2014) but don't coincide with Chao et al., (2008) . This may be explained by the difference in the site of transplantation, or the dose of cells. UCB-derived cells had higher ability to control hyperglycemia in rats in comparison to those derived from BM. To determine whether the transplanted IPCs could control hyperglycemia independently of the rat endogenous pancreatic β cells; the human C-peptide levels in serum of experimental rats were estimated. The study showed that the IPCs secreted measurable amounts of C-peptide, this finding coincides with previous report of human adipose tissue derived-MSCs (Chandra et al., 2011).However, the amount of C-peptide secreted from IPCs derived BM and UCB was not significant different . 
